SCHEMBL1492944

SCHEMBL1492944

Cc1cc(-c2ccc(NC(=O)NCc3ccco3)cc2)ccn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 1/20 0.61
PDGFRA P16234 1/20 0.61
KDR P35968 1/20 0.61
RAB9A P51151 4/20 0.59
TSHR P16473 2/20 0.59
MAPK1 P28482 2/20 0.56
TP53 P04637 1/20 0.56
ALDH1A1 P00352 3/20 0.55
KMT2A Q03164 2/20 0.55
HTT P42858 1/20 0.55
MEN1 O00255 1/20 0.55
HPGD P15428 2/20 0.55
KDM4E B2RXH2 1/20 0.55
MAPT P10636 1/20 0.55
ALOX15 P16050 1/20 0.55
CASP1 P29466 1/20 0.55
HSD17B10 Q99714 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
PSEN1 P49768 3/20 0.53
PSEN2 P49810 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1492815 0.89 PSEN1 (0.51) KITPDGFRAKDRRAB9ATSHR
SCHEMBL1492932 0.84 PSEN1 (0.53) MAPK1PSEN1PSEN2APH1BNCSTN
SCHEMBL10282263 0.80 SMN1; SMN2 (0.77) RAB9ATSHRMAPK1TP53ALDH1A1
SCHEMBL7964488 0.78 ROCK2 (0.62) MAPK1PSEN1PSEN2APH1BNCSTN
SCHEMBL1492962 0.78 WNT3A (0.56) MAPK1PSEN1PSEN2APH1BNCSTN
SCHEMBL7964831 0.78 ROCK2 (0.58) MAPK1KMT2AMEN1PSEN1PSEN2
SCHEMBL1492812 0.78 MAPK1 (0.62) MAPK1KDM4EPSEN1PSEN2APH1B
SCHEMBL1493028 0.78 PSEN1 (0.68) MAPK1PSEN1PSEN2APH1BNCSTN
SCHEMBL1492814 0.77 PSEN1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL28413942 0.77 KIT (0.74) KITPDGFRAKDRRAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083794-A Urea compounds as gamma secretase modulators AMGEN INC 2011-06-01 CN claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US claimed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP claimed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO claimed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 KIT 2443/4885PDGFRA 3325/4885KDR 4741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.